Home / Latest Science News -- ScienceDaily / Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma

Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma

Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/08/210806104354.htm
Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma Histone deacetylase inhibitor gel shows promise for the treatment of patients with basal cell carcinoma Reviewed by cmakigo on August 07, 2021 Rating: 5

You May Also Like

No comments:

Post a Comment

Subscribe to: Post Comments ( Atom )
'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.